Pelz, Lars
Dogra, Tanya
Marichal-Gallardo, Pavel
Hein, Marc Dominique
Hemissi, Ghada
Kupke, Sascha Young http://orcid.org/0000-0003-3943-9718
Genzel, Yvonne
Reichl, Udo
Funding for this research was provided by:
Max Planck Institute for Dynamics of Complex Technical Systems (MPI Magdeburg)
Article History
Received: 21 August 2023
Revised: 26 October 2023
Accepted: 5 November 2023
First Online: 13 January 2024
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the author.
: A patent for the use of OP7 as an antiviral agent for treatment of IAV infection is pending. Patent holders are S.Y.K. and U.R. In addition a patent for the use of DI244 and OP7 as an antiviral agent for treatment of coronavirus infection is pending. Patent holders are S.Y.K., U.R., and M.D.H.